Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$16K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| May 14 | ACRV | Acrivon Therapeutics, Inc. | FTAX | 613 | $1.92 | $1.2K | -0.8% | Open the original filing on SEC.gov |
| Mar 1 | ACRV | Acrivon Therapeutics, Inc. | AGRANT◆ | 186,728 | — | — | — | Open the original filing on SEC.gov |
| Feb 14 | ACRV | Acrivon Therapeutics, Inc. | FTAX | 723 | $1.63 | $1.2K | -1.0% | Open the original filing on SEC.gov |
| Jan 13 | ACRV | Acrivon Therapeutics, Inc. | PBUY | 10,000 | $1.72 | $17.2K | +15.3% | Open the original filing on SEC.gov |
| Nov 14, 2025 | ACRV | Acrivon Therapeutics, Inc. | FTAX | 613 | $2.24 | $1.4K | -0.9% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ACRV | Acrivon Therapeutics, Inc. | FTAX | 613 | $1.39 | $852 | -0.9% | Open the original filing on SEC.gov |
| May 14, 2025 | ACRV | Acrivon Therapeutics, Inc. | FTAX | 613 | $1.14 | $699 | -0.9% | Open the original filing on SEC.gov |